Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BICO Group AB Class B ( (SE:BICO) ) has issued an announcement.
BICO Group AB has announced the formation of its Nomination Committee for the 2026 Annual General Meeting, with members appointed by the company’s largest shareholders. This committee, representing approximately 44% of voting rights, will prepare proposals for board elections, auditor appointments, and other key decisions for the upcoming meeting, reflecting BICO’s commitment to structured governance and stakeholder engagement.
The most recent analyst rating on (SE:BICO) stock is a Hold with a SEK36.00 price target. To see the full list of analyst forecasts on BICO Group AB Class B stock, see the SE:BICO Stock Forecast page.
More about BICO Group AB Class B
BICO is a lab automation partner and provider of selected workflows to the pharma and biotech industries. With over 48,000 instruments installed in more than 65 countries, BICO’s products, software, and solutions are utilized in over 3,500 laboratories, including the world’s top 20 pharmaceutical companies. The company operates through two business areas: Lab Automation and Life Science Solutions, aiming to enable and automate the life science lab of the future. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO.
Average Trading Volume: 329,649
Technical Sentiment Signal: Sell
Current Market Cap: SEK1.5B
For a thorough assessment of BICO stock, go to TipRanks’ Stock Analysis page.